Meet Us at Antibody Engineering & Therapeutics 2018

ImmunoPrecise will be attending Antibody Engineering & Therapeutics 2018, the annual meeting of The Antibody Society, where you can find the latest science, technologies and partners in antibody engineering, immunobiology, and next generation biomarkers.

Meet Us at Booth 107

Meet with our global team at Booth #107 to find out more about our comprehensive collection of antibody discovery platforms and how we can accelerate next generation antibodies to commercial success. This event features plenty of opportunities for networking and collaborating with leading pharma, biotech, and academia from North America, Asia, and Europe.

Schedule a Meeting with us to learn about how we can further your therapeutic antibody discovery.

Location:
Manchester Grand Hyatt San Diego
San Diego, CA

Date:
December 9-13, 2018

Booth #107

ImmunoPrecise Attendees:

ImmunoPrecise Antibodies Ltd. Discusses Target Customer Base and Growth Drivers in an Interview with StockNewsNow

ImmunoPrecise’s CEO and President, Dr. Jennifer Bath spoke with SNNLive at the SmallCap Discoveries Conference 2018 in Vancouver.

Check Out the Video to Find out More On:

The overview and history of ImmunoPrecise Antibodies, what makes IPA unique in the marketplace, target customer base, the challenges pharmaceutical companies face when going through the process of outsourcing their pharmaceutical drug discovery, Dr. Bath’s background, and growth drivers.

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

info@stocknewsnow.com

SOURCE: StockNewsNow.com